ESPECIALIDADES FARMACEUTICAS CENTRUM, S.A. of ASAC PHARMA has performed and finished during 2009 the project named:

Clinical trial, phase IV, controlled monocentric, double blind study, to assess effect of curcuma extract Centrum, standardized at 12% curcumin, along with local phototherapy, with visible light, in adults diagnosed of mild to severe plaque psoriasis and an evolution of 6 months or more.

ESPECIALIDADES FARMACEUTICAS CENTRUM, S.A. of ASAC PHARMA has performed and finished during 2010 the project named:

Development of a blue visible light cabin for treatment of plaque psoriasis: phototherapy plus drug.

ESPECIALIDADES FARMACEUTICAS CENTRUM, S.A. of ASAC PHARMA has performed and finished during 2011 the project named:

Pilot clinical trial, phase IV to assess efficacy of treatment Curcuma Extract Centrum plus phototherapy with blue light vs. Oxoralen + UVA, in patients suffering from moderate to severe psoriasis.